Hidradenitis Suppurativa Market Expanding with Growing Disease Awareness and Increased Focus on Biologic and Targeted Treatment Options
The IL-17 Revolution: Redefining the Hidradenitis Suppurativa Treatment Paradigm What is the impact of IL-17 antagonism on current HS care? Hidradenitis Suppurativa (HS) has long been a domain of limited therapeutic options, largely dominated by TNF-alpha inhibitors. However, the emergence of IL-17 inhibitors represents a fundamental shift in treating moderate-to-severe cases. By targeting...
ไลค์
2
0 ความคิดเห็น 0 แชร์ 817 ยอดวิว 0 รีวิว